Humankind Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,690
Closed -$1.61M 30
2025
Q3
$1.61M Sell
5,690
-215
-4% -$62.4K 0.37% 36
2025
Q2
$1.65M Buy
5,905
+253
+4% +$71.7K 0.4% 35
2025
Q1
$1.76M Sell
5,652
-333
-6% -$98.3K 0.46% 31
2024
Q4
$1.56M Buy
5,985
+1,009
+20% +$299K 0.39% 33
2024
Q3
$1.6M Buy
4,976
+129
+3% +$42.2K 0.58% 29
2024
Q2
$1.51M Buy
4,847
+783
+19% +$230K 0.4% 34
2024
Q1
$1.16M Buy
4,064
+37
+0.9% +$10.8K 0.31% 42
2023
Q4
$1.16M Sell
4,027
-78
-2% -$21.3K 0.34% 38
2023
Q3
$1.1M Sell
4,105
-741
-15% -$185K 0.46% 30
2023
Q2
$1.08M Sell
4,846
-43
-0.9% -$9.98K 0.42% 35
2023
Q1
$1.18M Buy
4,889
+806
+20% +$198K 0.49% 30
2022
Q4
$1.07M Sell
4,083
-563
-12% -$151K 0.47% 32
2022
Q3
$1.05M Buy
4,646
+724
+18% +$175K 0.5% 29
2022
Q2
$954K Sell
3,922
-884
-18% -$217K 0.46% 30
2022
Q1
$1.16M Sell
4,806
-186
-4% -$42.7K 0.48% 29
2021
Q4
$1.12M Buy
4,992
+879
+21% +$186K 1.41% 18
2021
Q3
$875K Buy
4,113
+1,177
+40% +$271K 1.33% 21
2021
Q2
$716K Buy
2,936
+1,083
+58% +$266K 1.27% 27
2021
Q1
$461K Buy
+1,853
New +$442K 1.41% 24

Other funds holding AMGN

Humankind Investments's AMGN Position: Q4 2025 in Review

Humankind Investments sold out of Amgen (AMGN) in Q4 2025, closing a stake of 5,690 shares — an estimated $1.61M sold.

Humankind Investments first reported a position in AMGN in Q1 2021 and held it in 19 quarters. The position peaked at $1.76M in Q1 2025. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Humankind Investments reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 5,690 Amgen shares in Q4 2025, an estimated $1.61M.
  • Humankind Investments first reported a position in Amgen in Q1 2021 and held it in 19 quarters.
  • Humankind Investments's Amgen position peaked at $1.76M in Q1 2025.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.